Ajanta Pharma surges on tie-up news

DALAL STREET SPIKES

Ajanta Pharma rose nearly 9 per cent to Rs 108.95 after entering into an exclusive marketing tie-up with Prollenium Medical Technologies, Canada, to market the latter's dermal filler, Revanesse, in India.

The total dermatology market in the country is valued at about Rs 1,300 crore. The company believes that Revanesse will make it a frontrunner in the aesthetic segment in the country and boost its corporate equity.